Ying-Ru Lo Selected Research

Sexually Transmitted Diseases (Sexually Transmitted Disease)

1/2019	Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.
12/2013	Gonococcal antimicrobial resistance in the Western Pacific Region.
10/2013	Halting and reversing HIV epidemics in Asia by interrupting transmission in sex work: experience and outcomes from ten countries.
3/2013	Priority interventions to reduce HIV transmission in sex work settings in sub-Saharan Africa and delivery of these services.
1/2013	Serosorting and HIV/STI Infection among HIV-Negative MSM and Transgender People: A Systematic Review and Meta-Analysis to Inform WHO Guidelines.
5/2012	Socio-demographic characteristics and behavioral risk factors of female sex workers in sub-saharan Africa: a systematic review.
2/2012	Periodic presumptive treatment of curable sexually transmitted infections among sex workers: a systematic review.
1/2012	Impact of high-risk sex and focused interventions in heterosexual HIV epidemics: a systematic review of mathematical models.
6/2011	Male circumcision for prevention of homosexual acquisition of HIV in men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-Ru Lo Research Topics

Disease

9	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2019 - 06/2011
5	Acquired Immunodeficiency Syndrome (AIDS) 12/2014 - 10/2004
3	Syphilis 01/2021 - 06/2011
3	HIV Infections (HIV Infection) 01/2016 - 01/2015
2	Hepatitis B 01/2021 - 01/2019
2	Infections 01/2019 - 09/2011
2	Tuberculosis (Tuberculoses) 09/2011 - 09/2011
1	Disease Progression 11/2018
1	Chronic Hepatitis (Chronic Active Hepatitis) 12/2016
1	Hepatitis A (Hepatitis, Infectious) 12/2016
1	Hepatitis 12/2016
1	Neoplasms (Cancer) 01/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Coinfection 05/2012

Drug/Important Bio-Agent (IBA)

1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	hepatitis B hyperimmune globulinIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2016
1	CarcinogensIBA 01/2016
1	VaccinesIBA 07/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 07/2012
1	histidine-rich proteinsIBA 01/2012
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2004

Therapy/Procedure

5	Therapeutics 12/2016 - 10/2004
5	Condoms (Condom) 10/2013 - 02/2012
3	Art Therapy 01/2015 - 09/2010
2	Prenatal Care (Care, Prenatal) 01/2021 - 01/2019
2	Highly Active Antiretroviral Therapy (HAART) 01/2010 - 10/2004
1	Postnatal Care 01/2019
1	Continuity of Patient Care 12/2016
1	Male Circumcision 06/2011